Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1982-09-08
1985-02-05
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
424327, A61K 3115, A61K 31195
Patent
active
044978260
ABSTRACT:
An antiparkinsonian agent comprising DL- or L-threo-3,4-dihydroxyphenylserine and a decarboxylase inhibitor (e.g. carbidopa and benserazide), which is useful for the treatment of parkinson's disease, particularly treatment of the freezing phenomenon which has not previously been cured by the conventional antiparkinsonian drugs such as L-DOPA.
REFERENCES:
patent: 3920728 (1975-11-01), Hegedus et al.
patent: 4330558 (1982-05-01), Suzuki et al.
Merck Index, 1976 9th Ed., pp. 136, 228-229.
Archif Fur Psychiatrie und Zeitshrift f. d. ges. Neurologie 203, 560-574 (1962).
Carroll, "Clinical Pharmacology and Therapeutics" 12, 743-761 (1971).
Gunne et al, Scandinav. J. Clin. & Lab. Investigation 18, 425-430 (1966).
Bartholini et al, Biochemical Pharmacology 20, 1243-1247 (1971).
Porter et al, Life Sciences 11, Part I, 787-795 (1972).
Bartholini et al, The Journal of Pharmacology and Experimental Therapeutics 193, 523-532 (1975).
Folia Pharmacol. japon 72, 891-898 (1976).
Hayashi Akira
Kondo Tomoyoshi
Narabayashi Hirotaro
Suzuki Tomokazu
Friedman Stanley J.
Hayashi Akira
Kondo Tomoyoshi
Narabayashi Hirotaro
Sumitomo Chemical Company Limited
LandOfFree
Antiparkinsonian agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiparkinsonian agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiparkinsonian agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2082628